# Study in Healthy Adults to Quantify Lung Deposition and Distribution of Radio-labelled S-770108 Inhalation Powder Formulation Delivered by a Novel Inhaler Device

> **NCT04631354** · PHASE1 · COMPLETED · sponsor: **Shionogi** · enrollment: 12 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Radio-labelled S-770108
- **DEVICE:** S-770108 Inhaler A1

## Key facts

- **NCT ID:** NCT04631354
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-09
- **Primary completion:** 2020-12-14
- **Final completion:** 2020-12-21
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04631354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04631354, "Study in Healthy Adults to Quantify Lung Deposition and Distribution of Radio-labelled S-770108 Inhalation Powder Formulation Delivered by a Novel Inhaler Device". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04631354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*